The 17th Annual Meeting of Chinese Society of Clinical Oncology (CSCO) was held at Xiamen International Conference Center from Sep.17 to 21st, 2014. It was not only a grand meeting gathering clinical oncologists from the whole world to communicate and learn leading knowledge about Cancer Treatment, but also a magnificent event revealing research achievement and development about Clinical Oncology.

The theme of the meeting was “Improve Standardized Treatment Level, Broaden International Perspective”. With 59 Chinese sessions, 10 international symposiums, 48 satellite meetings and breakfast meetings, it attracted more than 20,000 oncologists from both home and abroad to share and communicate about the latest research results and about 1,200 academic papers.

The largest specialty of this annual meeting is International Joint Symposium

The International Sessions, co-organized with American Society of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO), International Association for the Study of Lung Cancer (IASLC), Japanese Society of Medical Oncology(JSMO), Society for Immunotherapy of Cancer (SITC), Chinese American Hematologist and Oncologist Network (CAHON), US Chinese Anti-Cancer Association( US CACA) and other international societies which use English as official language, attracted many leading professionals to come here and give speeches. Meanwhile, the conference also held special international sessions about lymphoma co-organized with union     for China Lymphoma Investigators and Jonathon Wood & Associates. All of them were very successful and impressive which not only promoted academic cooperation but also made great contributions to the global clinical oncology.

The plenary condensed the work and contribution of Chinese clinical oncologists in this year

Different with last conference, this year we changed the opening ceremony to plenary session in the afternoon of September 19th. We put it at such an important place because it included whole year’s endeavor.    

Prof. Yan Sun, Prof. Meilin Liao and Prof. Zhongzhen Guan, the three respected senior Chinese oncologists, acted as the Honorary Chairmen. Prof. Shukui Qin, Prof. Jun Ma and Prof. Yilong Wu served as the chairmen. “CSCO Annual Achievement Awards” was first issued. Prof. Shukui Qin from No. 81 Hospital got this award. After the award ceremony, Prof. Pasi A. Jänne from Dana Farber Cancer Institute gave the academic keynote speech which titled “Development of Immunotherapy and Targeted Therapy for Lung Cancer”. Also, there were four important oral presentations. The Immunotherapy of cancer has become the hot spot of cancer treatment and has been developed into a new stage. All these speeches strengthened the academic theme, revealed the achievement in this year and made the world heard more voice from China.

Diversify of Academic content in sessions.

CSCO arranged committee members to be responsible for each session. All of them are leading experts in clinical oncology and play important role in related societies. They are familiar with the recent trend and need on their respective area. This not only helped reflecting the hotspot of Chinese clinical oncology, but also reduced the duplication of sessions.

In the C-MET Targeted Therapy Symposium, Prof. Ilya Shmulevich from Institute for Systems Biology in the U.S made a brilliant speech on cancer genomics in bioinformatics which is noteworthy. Many bioinformatics analysis of cancer in America are completed by Prof. Shmulevich’s institute. His speech represented the most advanced contents in this area.

Multidisciplinary treatment (MDT), the cases discussion form always used by clinical oncologists, was also involved in many sessions in the annual meeting. In Gastrointestinal Cancer session, Lung Cancer session, Breast Cancer session etc., many CSCO young experts used the MDT the whole time. This is very useful for the combination of theory and practice.

In conclusion, the 2014 CSCO annual meeting was a grand international oncology gathering with distinct theme, vivid form and affluent content.